Bristol Myers Squibb facility in Moreton, UK, exemplifies sustainability innovation
April 21, 2022
R&D facility building in the UK exemplifies sustainability innovation >
Consumer wearable technology advancements may support AFib detection
April 15, 2022
Consumer wearable technology advancements may support AFib detection >
COLORS Training Program
April 11, 2022
COLORS training program spreads education of healthcare needs in the LGBTQ+ community >
Bristol Myers Squibb scientists Kim Harrington (left) and Ruth Salmon
April 04, 2022
Give and take: The power of mentorship at Bristol Myers Squibb >
Bristol Myers Squibb Cancer Support Network
March 24, 2022
‘We take care of our BMS family’ – Bristol Myers Squibb Cancer Support Network >
Early development center to open in Cambridge Crossing
March 03, 2022
New state-of-the-art research and early development center to open in Cambridge Crossing >
Bristol Myers Squibb’s Thomas O. Daniel Research Incubator and Collaboration Center
February 14, 2022
Unleashing innovation through incubators and beyond >
Adam Lenkowsky, senior vice president and general manager of U.S. Cardiovascular, Immunology and Oncology, Bristol Myers Squibb
February 07, 2022
Advancing our commitment to health equity  >
Joining forces to advance heart failure research
February 07, 2022
Joining forces to advance heart failure research >
December 15, 2021
How Bristol Myers Squibb supports military members like Ken Faria >
Global HOPE treats 10,000th child
December 10, 2021
Global HOPE treats 10,000th child  >
Medical Team handshaking
December 10, 2021
Diversifying Clinical Trials: A global initiative with local roots >